Home Newsfeeds HC Wainwright & Co. Downgrades Vascular Biogenics to Neutral

HC Wainwright & Co. Downgrades Vascular Biogenics to Neutral

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Vascular Biogenics (NASDAQ:VBLT) from Buy to Neutral.

byBenzinga Newsdesk

July 20, 2022

1 minute read

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Vascular Biogenics (NASDAQ:VBLT) from Buy to Neutral.

Canadian Pot Company Adds Tobacco, Private Label Products, CPG To Its Offering

By Nina Zdinjak

September 26, 8:22 AM

Marijuana and liquor retail company, 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) announced Tuesday the addition of tobacco, vape & consumer packaged goods products to its retail portfolio.

CSE:EPIC

Morgan Stanley Maintains Equal-Weight on Alcoa, Lowers Price Target to $52

By Benzinga Newsdesk

January 20, 9:19 AM

Morgan Stanley analyst Carlos De Alba maintains Alcoa (NYSE:AA) with a Equal-Weight and lowers the price target from $56 to $52.

Kinetik To Reiterate High End Of FY23 Guidance After Q2, Analyst Forecasts Linear Growth Trajectory

By Nabaparna Bhattacharya

July 21, 1:14 PM

Mizuho analyst Gabriel Moreen reiterated a Buy rating on Kinetik Holdings Inc. (NYSE: KNTK),

KNTK

M&A
News

Hollysys Receives Notices of Intention to Request Special Meeting of Shareholders and Additionally an Unsolicited Offer from Recco Control Technology and Dazheng Group to Acquire the Company at $25.00/Share in cash.

By Benzinga Newsdesk

September 5, 6:02 AM

Hollysys Automation Technologies Ltd. (NASDAQ:HOLI) ("Hollysys" or the "Company") announced that on August 23, 2023, it received from certain shareholders of the Company, notices of intention

HOLI

HC Wainwright & Co. Downgrades Vascular Biogenics to Neutral

Related Posts

Canadian Pot Company Adds Tobacco, Private Label Products, CPG To Its Offering

Morgan Stanley Maintains Equal-Weight on Alcoa, Lowers Price Target to $52

Kinetik To Reiterate High End Of FY23 Guidance After Q2, Analyst Forecasts Linear Growth Trajectory

Hollysys Receives Notices of Intention to Request Special Meeting of Shareholders and Additionally an Unsolicited Offer from Recco Control Technology and Dazheng Group to Acquire the Company at $25.00/Share in cash.